Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study

Objective To determine whether better medication adherence in multiple sclerosis (MS) might be due to specialised disease-modifying drug (DMD) support programmes by: (1) establishing higher adherence in MS than in other chronic diseases and (2) determining if higher adherence is associated with pati...

Full description

Bibliographic Details
Main Authors:	Shenzhen Yao, Randy Walld, Elaine Kingwell
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-02-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/11/2/e043930.full

Similar Items

Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis
by: Efrat Neter, et al.
Published: (2021-03-01)

Treatment satisfaction and adherence to medications among multiple sclerosis patients in Saudi Arabia
by: Adel Alhazzani, et al.
Published: (2019-08-01)

Adherence to chronic medication in older populations: application of a common protocol among three European cohorts
by: Menditto E, et al.
Published: (2018-10-01)

Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study
by: Zimmer A, et al.
Published: (2017-10-01)

Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study
by: Zimmer, Andrea, et al.
Published: (2017)

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
by: Kyla McKay, et al.
Published: (2017-04-01)

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients
by: Dhamane AD, et al.
Published: (2016-12-01)

Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
by: Lizán L, et al.
Published: (2014-12-01)

Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
by: Kerstin Hansen, et al.
Published: (2015-01-01)

Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data
by: Bawa, K., et al.
Published: (2021)

Adherence to clean intermittent catheterization in patients with multiple sclerosis
by: A. Zachariou, et al.
Published: (2020-07-01)

The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis
by: M. Tarrants, et al.
Published: (2011-01-01)

Examining adherence, perceptions, and symptoms in patients with Multiple Sclerosis
by: Suh, Kangho
Published: (2013)

Adherence to disease-modifying therapies in patients with multiple sclerosis
by: Kołtuniuk A, et al.
Published: (2018-08-01)

Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT® Autoinjector: A Prospective Observational Cohort Study
by: Wolfgang Köhler, et al.
Published: (2021-02-01)

The effects of bone mineral density testing on health related behaviours in a randomly selected population of Canadians
by: Kingwell, Elaine
Published: (2011)

The prevalence of internuclear ophthalmoparesis in a population-based cohort of individuals with multiple sclerosis
by: de Ruiter, L.R.J, et al.
Published: (2022)

Proposals to improve adherence to immunomodulatory therapies in patients with multiple sclerosis
by: E. Arroyo, et al.
Published: (2010-01-01)

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence
by: Francesco Patti
Published: (2010-01-01)

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
by: Morillo Verdugo R, et al.
Published: (2019-02-01)

Treatment adherence in multiple sclerosis: a survey of Belgian neurologists
by: Decoo D, et al.
Published: (2015-11-01)

Factors associated with adherence to immunomodulator treatment in people with multiple sclerosis
by: Nair Assunta Antônia Corso Câmara, et al.
Published: (2017-04-01)

Non-adherence to Disease-Modifying Treatments in Patients with Multiple Sclerosis
by: Seyed-Ali Roudbary, et al.
Published: (2017-08-01)

Pharmacoeconomic aspects of poor adherence to treatment in multiple sclerosis management
by: Mario Eandi
Published: (2011-09-01)

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis
by: Gisela Zanga, et al.
Published: (2021-10-01)

Medication adherence in the general population.
by: Julia A Glombiewski, et al.
Published: (2012-01-01)

Genome-Wide Association Study of Medication Adherence in Chronic Diseases in the Korean Population
by: Incheol Seo, et al.
Published: (2014-09-01)

Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population
by: Huang YC, et al.
Published: (2021-02-01)

Adherence to Therapy, Physical and Mental Quality of Life in Patients with Multiple Sclerosis
by: Alessandra Buja, et al.
Published: (2021-07-01)

Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
by: Alosaimi FD, et al.
Published: (2017-03-01)

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study
by: Ingo Kleiter, et al.
Published: (2017-09-01)

Myelitis: Differences between multiple sclerosis and other aetiologies
by: S. Presas-Rodríguez, et al.
Published: (2016-03-01)

Prevalence, socio-demographic characteristics, and comorbid health conditions in pre-dialysis chronic kidney disease: results from the Manitoba chronic kidney disease cohort
by: Mariette J Chartier, et al.
Published: (2018-10-01)

The Impact of Adherence to Disease-Modifying Therapies on Functional Outcomes in Veterans with Multiple Sclerosis
by: Meheroz H Rabadi, et al.
Published: (2021-07-01)

Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain.
by: Oscar Fernández, et al.
Published: (2012-01-01)

Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis
by: Damien Motavasseli, et al.
Published: (2018-06-01)

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
by: Bayas A, et al.
Published: (2015-02-01)

Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale.
by: Gabrielle K Y Lee, et al.
Published: (2013-01-01)

Potential pathogens in multiple sclerosis (MS
by: Mariola Zawada
Published: (2012-10-01)

Multiple sclerosis - etiology and diagnostic potential
by: Joanna Kamińska, et al.
Published: (2017-06-01)